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Abstract 
Background: Probiotic bacteria can induce immune regulation or immune tolerance in patients with allergic 
diseases, but the underlying mechanisms are still unclear. There has been a growing interest in the use of beneficial 
bacteria for allergic diseases recently. This study aimed at exploring whether Clostridium butyricum CGMCC0313-1 (C. 
butyricum) can reduce β-lactoglobulin(BLG)-induced intestinal anaphylaxis in a murine model of food allergy.
Methods: The preventive and therapeutic effects of oral C. butyricum on anaphylactic symptoms induced via BLG in 
food allergy mice were investigated. Intestinal anaphylaxis, T helper (Th)-specific cytokines and transcription factors, 
secretory IgA (sIgA), CD4+ CD25+ Foxp3Treg cell and histopathological alterations were examined.
Results: Clostridium butyricum significantly ameliorated intestinal anaphylaxis symptoms in the food allergy mice. 
sIgA and CD4+ CD25+ Foxp3Treg cell were increased by oral C. butyricum. It also reversed the imbalance of Th1/Th2 
andTh17/Treg.
Conclusions: Clostridium butyricum reduces BLG-induced intestinal anaphylaxis in mice and might be an additional 
or supplementary therapy for food allergy.
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Background
Food is a foreign antigen that is necessary for nutrition. 
Inevitably, food antigens present a continuous challenge 
throughout life. Humans have adapted to food via mech-
anisms of immune tolerance. Food allergy is defined as 
abnormal immune responses resulting from breakdown 
of natural oral tolerance [1]. Food allergy is an increas-
ing public health problem worldwide [2–5] and has been 
estimated to affect approximately 5% of adults and 8% of 
children [6]. Among food allergies, cow’s milk allergy is 
one of the earliest and most prevalent food allergies and 
β-lactoglobulin (BLG) is the major allergen [7, 8]. Diets 
based on cow’s milk play a major role in children’s nutri-
tion as it has an essential effect on the patient’s quality of 
life. Additionally, up to now the current standard for pre-
vention of food allergy is still the strict allergen avoidance 
and the elimination of the triggering food from the diets 
[9]. However, accidental ingestion is difficult to be abso-
lutely avoided in our life. Therefore, effectively prevent 
and manage food allergy to restore immune tolerance is 
particularly needed.
A previous study shows that the increased prevalence 
of allergic diseases is associated with decreased micro-
bial exposure and alteration of microbial communities 
represented in the gut microbiota [10]. It has been dem-
onstrated that the composition and metabolic activity of 
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the microbiota is crucial for both the maintenance and 
the development of immune homeostasis, as well as the 
induction of immune tolerance [11, 12]. Intervention 
strategies targeting the intestinal microbiota include the 
deliberate administration of probiotic bacteria. Probiot-
ics are live microorganisms that confer a health benefit 
to the host when administered in adequate amounts [13]. 
Different bacterial strains or their mixtures have been 
used to assess their protective effects for allergic diseases 
in clinical trials, but the results have been controversial 
[14–16]. Possible mechanisms of their protective action 
include both the induction of regulatory dendritic cells 
(regDCs) and T cells and the skewing the imbalances 
of T helper (Th)1/Th2 as well as Th17/Treg, together 
with the enhancement of the epithelial barrier func-
tion [10, 17–21]. Imbalances in Th responses can also be 
detected using Th-specific transcription factors: T-bet 
for Th1 cells, GATA-3 for Th2 cells, retinoic acid orphan 
receptor-γt (RORγt) for Th17 cells and forkhead box P3 
(Foxp3) for Tregs [22]. Nevertheless, the knowledge of 
molecular mechanisms underlying probiotic-host inter-
actions that shape host immune system in a protective 
setting is still incomplete. Mouse models of food allergy 
to clinically relevant allergens could be helpful in provid-
ing information difficult to be obtained in human studies.
Clostridium butyricum CGMCC0313-1 (C. butyricum) 
has been widely used for improving gastrointestinal func-
tion as probiotics [23, 24]. However, the benefit of C. 
butyricum on food allergy is rarely reported. This study 
aimed to explore whether oral C. butyricum can reduce 
food allergy in mice. Findings from this study will con-
tribute to a better understanding of the protective effects 
of the beneficial bacteria in allergic diseases.
Methods
Mice
Male BALB/c mice of 6–8  weeks were purchased from 
the Laboratory Animal Center of the Fourth Mili-
tary Medical University and acclimated to their new 
environment for 1  week. Animals were housed under 
conventional conditions, fed standard mouse pellets 
and water  adlibitum. Experimental procedures were 
approved by the Ethics Committee for Animal Studies 
of the Fourth Military Medical University (20150901) 
and performed in accordance with their guidelines of the 
Institutional Animal Care and Use Committee.
The probiotics
The C. butyricum powder (Kexing Biotech Company lim-
ited, Weifang, Shandong, China) was stored at −20  °C. 
Drinks were prepared using normal saline (NS) only or 
NS plus C. butyricum. The concentration of C. butyricum 
was 5 × 108 CFU/ml.
Mouse model of food allergy
BALB/c mice were randomly assigned into 4 experimen-
tal groups with 10 in each group. The 4 groups of mice 
were treated as follow: the food allergy group received 
20 mg BLG (Sigma, St. Louis, MO, USA) plus 10 μg chol-
era toxin(CTX, Sigma) orally on days 7, 14 and 21, and 
followed by oral administration of 100  mg BLG chal-
lenge on day 28; the preventive and treated groups were 
approached as the food allergy group, and the animals 
were given 200 μl C. butyricum feeding from days 1 to 21 
or from days 22 to 28 respectively; mice from the control 
group only received 10  μg CTX orally, and followed by 
challenge with NS (Fig. 1).
Sample collection
Challenge: BLG or 
NS
Sensitization: BLG
plus CTX or CTX
C. butyricum C. butyricum
D0 D7 D14  D21 D28 D29
Prevention: Treatment:
Fig. 1 The protocols used for the mouse models of food allergy. Male BALB/c mice were sensitized orally with BLG plus CTX or only CTX on day 7, 
14 and 21, and followed by oral administration of 100 mg BLG challenge on day 28. The animals received C. butyricum feeding from day 1 to day 21 
or from day 22 to day 28 by oral gavage
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Measurement of intestinal anaphylaxis
Intestinal anaphylaxis was assessed in challenged mice 
by the allergic diarrhea and circulating mouse mast cell 
protease 1 (mMCP-1) levels as previously described [25, 
26]. Briefly, mice were observed for the presence of diar-
rhea for 1 h after the challenge and were scored as diar-
rhea positive or negative. Diarrhea and anaphylactic 
symptoms were scored by visually monitoring mice for 
60  min after challenge. Diarrhea—0, normal stools; 1, 
a few wet and unformed stools; 2, a number of wet and 
unformed stools with moderate perianal staining of the 
coat; 3, severe, watery stool with severe perianal staining 
of the coat. Anaphylactic symptoms—0, no symptoms; 
1, reduced activity, trembling of limbs; 2, loss of con-
sciousness, no activity upon prodding; 3, convulsions, 
death. Serum was obtained 1 h following the final antigen 
challenge for measurement of mMCP-1 using the com-
mercial enzyme-linked immunosorbentassay (ELISA) 
(eBioscience, San Diego, CA, USA) according to manu-
facturer instructions (Table 1).
The measurement of cytokines and immunoglobulin
Serum samples were collected to assay the presence of 
cytokines and immunoglobulin (Ig). Levels of serum IL-4, 
IL-5, IL-13, IL-17, INF-γ, IL-10, TGF-β1 and the total IgE 
were measured by ELISA Kits (RD system, Boston, MA, 
USA; Uscn Life, Wuhan, Hubei, China) following the 
manufacture’s protocol.
Secretory IgA
Small intestine was rinsed with 10 ml of cold PBS. Intes-
tinal lavages were centrifuged at 12,000×g for 20 min at 
4  °C, and levels of secretory IgA (sIgA) in the superna-
tants were determined by ELISA (Uscn Life) as previ-
ously described [27].
RNA isolation and quantitative real‑time PCR
After mice were sacrificed on day 29, the spleen was dis-
sected and immersed in RNAlater® (Ambion, Austin, TX, 
USA) for PCR. Total RNA (n =  6 mice per group) was 
carried out using Trizol (Ambion) from whole spleen tis-
sue and reverse-transcribed to cDNA by a PrimeScript™ 
RT Master Mix Kit (TaKaRa, Tokyo, Japan). cDNA was 
amplified using SYBR® Premix Ex Taq™ II Kit (TaKaRa) 
and run in the Real-Time PCR Detection System. Primers 
for T cell transcription factors were designed and  syn-
thesized by TaKaRa Biotechnology (Dalian, Liaoning, 
China). The sequences were listed in Table 2. The relative 
levels of gene expression were calculated by reference to 
the level of β-actin using the ΔΔCT method [28].
Flow cytometry
Single-cell suspensions isolated from mesenteric 
lymph nodes (MLN) were stained for FACS analyses as 
described previously [29]. Cells were first stained for sur-
face markers including CD4-PerCP-Cy5.5, CD25-FITC 
(BD Pharmingen, San Diego, CA, USA). If required, cells 
were then fixed and permeabilized by BD Cytofix/Cytop-
erm reagent (BD Bioscience, San Jose, CA, USA) and 
stained for intracellular expression markers, Foxp3-PE. 
Data were acquired with FACSCanto (Beckman Coulter, 
Miami, FL, USA) and analyzed by FlowJo 10.0.7 software.
Histological analysis
Paraffin-embedded sections of proximal jejunum were 
stained with hematoxylin and eosin (H&E) for morpho-
logical analysis. Villus length was determined by meas-
uring the distance in μm from the crypt neck to the 
villus tip using Image J software. Six animals from each 
experimental group were evaluated, and a minimum of 
12 well-oriented villi from each section were measured. 
Data were reported as villus size measured in μm. Mor-
phological analyses were performed in a blinded manner 
to prevent observer bias.
Table 1 Scoring methods of diarrhea and anaphylactic symptoms
Diarrhea Anaphylactic symptoms Scores
Normal stools No symptoms 0
A few wet and unformed stools Reduced activity, trembling of limbs 1
A number of wet and unformed stools with moderate perianal staining of the coat Loss of consciousness, no activityupon prodding 2
Severe, watery stool with severe perianal staining of the coat Convulsions, death 3
Table 2 Oligonucleotide primers used in the study
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Statistical analysis
Data were expressed as the mean ± standard error means 
(SEMs). All data were analyzed with SPSS17.0 software 
(SPSS Inc, Illinois, Chicago, USA). One-Way ANOVA 
and Mann–Whitney U non-parametric test was con-
ducted to determine the statistical significance, where 
appropriate. A P value of  <0.05 was considered statisti-
cally significant.
Results
Clostridium butyricum ingestion inhibits the development 
of intestinal anaphylaxis
Oral challenges with BLG in sensitized mice lead to 
increasing severity of diarrhea and anaphylaxis, and a 
robust increase in circulating mMCP-1. Administration 
of C. butyricum obviously inhibited BLG-induced food 
allergy, namely diarrhea occurrence and scores (Fig. 2a), 
Fig. 2 Clostridium butyricum inhibits the development of intestinal anaphylaxis. Diarrhea occurrence, diarrhea scores (a), anaphylactic response, 
anaphylactic score (b) and levels of mMCP-1 (c) were monitored. Male BALB/c mice were given NS or sensitized/challenged with BLG ± treatment 
with C. butyricum. Con, n = 10 for the control group; FA, n = 10 for the food allergy group; Pre, n = 10 for the preventive group; and Tre, n = 10 
for the treated group. Results are shown as means ± SEMs. *P < 0.05, **P < 0.01, ***P < 0.001 versus the control group, and #P < 0.05, ##P < 0.01, 
###P < 0.001 versus the food allergy group
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anaphylactic response and scores (Fig. 2b), and levels of 
mMCP-1 (Fig.  2c), suggesting a protective effect of C. 
butyricum on food allergy in mice.
Cytokines and immunoglobulin
Cytokines and total IgE were determined using ELISA 
Kits (Fig. 3). Compared with the control group, the lev-
els of inflammatory cytokines in the serum (Fig.  3a–d: 
IL-4, IL-5, IL-13, IL-17) were significantly increased in 
the food allergy group and decreased in the preventive 
and treated groups. However, the IL-17 of the preven-
tive group was not significant different from that of the 
food allergy group (P  >  0.05). Levels of INF-γ, IL-10 
and TGF-β1 (Fig. 3e–g) in the food allergy group were 
decreased compared with the counterparts of the con-
trol group. They increased in the groups received C. 
butyricum orally except for the IL-10 in the preventive 
group.
Compared with the control group, the total IgE 
(Fig.  3h) was significantly elevated in the food allergy 
group (P  <  0.01). However, they decreased dramatically 
in the preventive and treated group.
Clostridium butyricum supress the intestinal levels of sIgA
Since sIgA contributes to the barrier function and it is 
involved in immunological homeostasis [30], we meas-
ured levels of this immunoglobulin in small intestinal 
lavage fluids. sIgA levels were augmented in allergic mice 
following local inflammation. C. butyricum was effec-
tive in suppressing such augment in the preventive and 
treated group (Fig. 4).
Clostridium butyricum results in a strong up‑regulation 
of mRNA for Tbet and Foxp3
To further explore the effects of the different interven-
tions on Th responses in the spleen, the mRNA expres-
sion of Th specific transcription factors was measured 
(Fig. 5). The expression of Th1-(Tbet) and Treg-(Foxp3) 
transcription factors was significantly decreased in the 
food allergy group as compared to the control group, 
whereas the expression of Th2-(Gata3) and Th17-(Rorγt) 
transcription factors increased dramatically. However, 
Tbet and Foxp3 expression were significantly increased 
Fig. 3 The effect of C. butyricum on cytokines and immunoglobulin. Levels of serum IL-4 (a), IL-5 (b), IL-13 (c), IL-17 (d), INF-γ (e), IL-10 (f), TGF-β1 (g) 
and the total IgE (h) were measured by ELISA Kits. Male BALB/c mice were given NS or sensitized/challenged with BLG ± treatment with C. butyri-
cum. Con, n = 10 for the control group; FA, n = 10 for the food allergy group; Pre, n = 10 for the preventive group; and Tre, n = 10 for the treated 
group. Results are shown as means ± SEMs. *P < 0.05, **P < 0.01, ***P < 0.001 versus the control group, and #P < 0.05, ##P < 0.01, ###P < 0.001 versus 
the food allergy group
Fig. 4 Clostridium butyricum supress the intestinal levels of sIgA. 
Levels of sIgA were determined by ELISA. Male BALB/c mice were 
given NS or sensitized/challenged with BLG ± treatment with C. 
butyricum. Con, n = 10 for the control group; FA, n = 10 for the food 
allergy group; Pre, n = 10 for the preventive group; and Tre, n = 10 
for the treated group. Results are shown as means ± SEMs. *P < 0.05, 
**P < 0.01, ***P < 0.001 versus the control group, and #P < 0.05, 
##P < 0.01, ###P < 0.001 versus the food allergy group
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in the preventive group. Compared to the food allergy 
group, Tbet expression was increased in the treated 
group, however, the expression of Foxp3 remained 
unchanged.
Clostridium butyricum skews the immune response away 
from Th2 and towards Treg
To determine the extent of Th response skewing in the 
spleen, ratios for Gata3/Tbet (Th2/Th1), Foxp3/Rorγt (Treg/
Th17), Foxp3/Gata3 (Treg/Th2) and Foxp3/Tbet (Treg/
Th1) mRNA expression were calculated (Fig.  6). The food 
allergy groups showed a Th2-skewed immune response 
represented by a significant increase in Gata3/Tbet ratio 
as compared to control group. C. butyricum reduced this 
ratio in the treated group, but not the preventive group. 
Interestingly, the Foxp3/Rorγt (except for the treated group)
and Foxp3/Gata3 ratios were significantly increased in the 
groups received C. butyricum orally as compared to the 
food allergy group indicating an increase in Treg-associated 
responses. The ratio of Foxp3/Tbet did not differ signifi-
cantly among the different treatment groups.
The effect of C. butyricum on Treg cell
We examined the potential induction of Foxp3 by regula-
tory T cells in the MLN of the mice. Food allergy mice 
had a lower percentage of CD4+  CD25+  Foxp3+  T 
cells in the MLN compared to nonsensitized controls. 
The numbers of CD4+  CD25+  Foxp3+  Treg cells was 
increased in the preventive group, however, no signifi-
cant differences in these regulatory T-cell populations 
were observed in the treated group as compared to the 
food allergy group (Fig. 7).
Clostridium butyricum reduces histological changes 
in allergic mice
Ingestion of BLG induced submucosal edema and 
increased inflammatory cell infiltration in the gut of 
sensitized mice (Fig. 8a). Allergic mice had decrease vil-
lus height whereas C. butyricum-treatment animals 
had a similar alteration to the one found in the control 
mice (Fig. 8b). Thus, oral administration of C. butyricum 
reduced the development of intestinal inflammation.
Discussion
Food allergy is an increasing health problem and it has 
a significant impact on the health and daily activities of 
allergic individuals. The aim of this study was to inves-
tigate the preventive and therapeutic effect of C. butyri-
cum on food allergy in mice. In our study, there were 
higher scores about diarrhea and anaphylactic symptoms 
in the food allergy group as compared to the control 
group. Positive incidence of mice with allergic diarrhea 
and anaphylactic symptoms was increased in the food 
allergy mice. Additionally, the expression of mMCP-1 
and total  IgE were significantly increased in the aller-
gic mice. These were similar to the results observed in 
a study of ovalbumin allergy [31], however, we lack the 
data about BLG specific IgE due to the unavailable of the 
Fig. 5 Clostridium butyricum up-regulates Tbet and Foxp3 mRNA 
expression. The mRNA expression of Th specific transcription factors 
was measured by quantitative real-time PCR. Male BALB/c mice were 
given NS or sensitized/challenged with BLG ± treatment with C. 
butyricum. Con, n = 10 for the control group; FA, n = 10 for the food 
allergy group; Pre, n = 10 for the preventive group; and Tre, n = 10 
for the treated group. Results are shown as means ± SEMs. *P < 0.05, 
**P < 0.01, ***P < 0.001 versus the control group, and #P < 0.05, 
##P < 0.01, ###P < 0.001 versus the food allergy group
Fig. 6 Clostridium butyricum skews the immune response away 
fromTh2 and towards Treg. Ratios for Gata3/Tbet (Th2/Th1), Foxp3/
Rorγt (Treg/Th17), Foxp3/Gata3 (Treg/Th2) and Foxp3/Tbet (Treg/
Th1) mRNA expression in whole spleen tissue are shown for each C. 
butyricum treatment. Male BALB/c mice were given NS or sensitized/
challenged with BLG ± treatment with C. butyricum. Con, n = 10 for 
the control group; FA, n = 10 for the food allergy group; Pre, n = 10 
for the preventive group; and Tre, n = 10 for the treated group. 
Results are shown as means ± SEMs. *P < 0.05, **P < 0.01, ***P < 0.001 
versus the control group, and #P < 0.05, ##P < 0.01, ###P < 0.001 versus 
the food allergy group
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kit from the manufacturer. More importantly, decreased 
villus length and increased inflammatory reaction were 
observed in the gut slides of the food allergy mice. Hence, 
we successfully mimic BLG-induced allergic intestine 
inflammation in our mouse model.
Various strains of probiotics have been used in ani-
mal models of food allergy. Probiotic VSL#3-induced 
TGF-β ameliorates food allergy inflammation in a mouse 
model of peanut sensitization through the induction 
of regulatory T cells in the gut mucosa [32]. A combi-
nation of specific immunotherapy with C. butyricum 
significantly enforces the therapeutic effect on inhibit-
ing the food allergen related inflammation in the intes-
tine, which can be a novel approach for the treatment 
of food allergy [33]. A recent study suggests that oral 
supplementation of Lactobacillus paracasei L9 (L9) can 
reduce the development of allergic sensitization to BLG, 
likely through regDCs mediated active suppression [34]. 
In a BALB/c mouse model of BLG allergy, oral admin-
istration of Lactobacillus acidophilus (L. acidophilus)
can suppress the major allergic symptoms probably due 
to improve the regulatory T (Treg)/Th17 balance and 
inhibit the IL-6 production [35]. It has been confirmed 
that Bifidobacterium longum BBMN68 (BBMN68) may 
be a suitable therapeutic approach to the alleviation of 
food allergies likely through the specific induction of 
CD11c+ CD103+ DCs and semi-mature DCs [36]. Simi-
larly, oral administration of C. butyricum to the mouse 
models of food allergy is effective in reducing allergic 
inflammation in our study.
Th2 cells play a key role in the pathogenesis of food 
allergy, and patients with food allergy were reported 
to have Th1/Th2 imbalances as well as disturbed Th17/
Treg balances. Th2 cytokines including IL-4, IL-5, IL-13 
[37]. IFN-γ released by Th1 can inhibit the development 
of Th2. Th17 cells release IL-17 which is connected with 
inflammation in the gut [38, 39]. High levels of IL-10, 
TGF-β expressed by regDCs can directly mediate the 
conversion of T cells into Foxp3+ Treg cells and induce 
immune tolerance [17]. Th2 dominance was observed 
in the food allergy group represented by a significant 
decrease in Th1 and Treg transcription factors and high 
Gata3/Tbet ratio. Hence, our model mimics the Th2-
responses found in food allergy. Importantly, C. butyri-
cum shifted the immune balance towards Th1 and Treg, 
with significantly increased Foxp3/Rorγt and Foxp3/
Gata ratios and a significantly decreased Gata3/Tbet 
ratio. These findings are consistent with results of those 
Fig. 7 The effect of C. butyricum on Treg cell. The gating strategy (a) and effect of oral administration of C. butyricum on populations of 
CD4+ CD25+ Foxp3+ (b) cells in the MLN. Male BALB/c mice were given NS or sensitized/challenged with BLG ± treatment with C. butyricum. 
Con, n = 10 for the control group; FA, n = 10 for the food allergy group; Pre, n = 10 for the preventive group; and Tre, n = 10 for the treated group. 
Results are shown as means ± SEMs. *P < 0.05, **P < 0.01, ***P < 0.001 versus the control group, and #P < 0.05, ##P < 0.01, ###P < 0.001 versus the food 
allergy group
Page 8 of 10Zhang et al. Gut Pathog  (2017) 9:11 
previous studies. BBMN68 and L9 has been already 
shown to significantly reduce BLG-specific  hypersen-
sitivity  reactions by suppressing the aberrant balance 
of  Th1/Th2  responses with increasing the number of 
CD4+  CD25+  Foxp3+  Treg cells [34, 40]. L. acido-
philus supplementation is capable of reducing allergic 
symptoms in a mouse model of food allergy through 
reversing the imbalance of regulatory T (Treg)/Th17. 
More importantly, the above observed effects of ben-
eficial bacteria on the Th responses are mirrored by 
the detection of CD4+  CD25+  Foxp3+  Tregs in the 
MLN of the animals. Tregs play a key role in balanc-
ing immune responses and it was demonstrated that 
increased expression of Foxp3 in Tregs is directly 
associated with increased function of these cells [41]. 
Preventive ingestion of C. butyricum increase the pop-
ulations of CD4+ CD25+ Foxp3+ cells in the MLN and 
induced high levels of TGF-β and IL-10 in the serum, 
indicating the powerful effect of probiotics on modu-
lating the intestinal immune response. These were sim-
ilar to results observed in a study of ovalbumin allergy, 
which showed that LGG only induced the number of 
CD4+ CD25+ Foxp3+ Treg cells and TGF-β secretion 
[42]. However, No significant differences in the per-
centage of CD4+ CD25+ Foxp3+  cells were observed 
in the treated group as compared with the food allergy 
group.
sIgA plays a protective role by antigen binding and 
exclusion [43]. Food allergy may cause impaired epithe-
lial barrier function, including sIgA release into the gut 
lumen [44]. We observed enhanced levels of sIgA in feces 
of the food allergy mice. sIgA can mediate a potent anti-
inflammatory  function following the interaction with 
SIGNR1 on DC which induces an immune tolerance via 
regulatory T cell expansion [45]. Therefore, the increase 
of the protective secretory immunoglobulin might be a 
regulatory mechanism triggered to counteract allergic 
inflammation to BLG in the gut mucosa. Levels of sIgA 
enhanced in allergic mice suggesting that inflamma-
tion triggered this modulatory component of immune 
response. The groups received C. butyricum orally, on the 
other hand, had little inflammatory consequences and 
therefore were not accompanied by augmented levels of 
sIgA.
Conclusions
To our knowledge, this is the first report in which the 
preventive and therapeutic effects of C. butyricum on 
food allergy were investigated. The findings reported here 
indicate that oral probiotics such as C. butyricum, with 
Fig. 8 Clostridium butyricum reduces histological changes in allergic mice. Representative H&E staining of intestinal sections (a, 200× magnifica-
tion). Bar graph of villus height (b) determined by measuring vertically well-oriented crypt villus units from H&E-stainedsections of mice. Male 
BALB/c mice were given NS or sensitized/challenged with BLG ± treatment with C. butyricum. Con, n = 10 for the control group; FA, n = 10 for 
the food allergy group; Pre, n = 10 for the preventive group; and Tre, n = 10 for the treated group. Results are shown as means ± SEMs. *P < 0.05, 
**P < 0.01, ***P < 0.001 versus the control group, and #P < 0.05, ##P < 0.01, ###P < 0.001 versus the food allergy group
Page 9 of 10Zhang et al. Gut Pathog  (2017) 9:11 
established anti-inflammatory and anti-allergic activity, 
can significantly modulate the mucosal immune response 
and may represent an effective and safe strategy for 
patients with food allergies, for which no established and 
effective cures based on the pathogenetic mechanisms 
are available.
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